Antioxidant and Anti-Inflammatory Activities of Kigelia africana (Lam.) Benth.

Table 3

Inhibition of nitric oxide (NO) production by Kigelia africana extracts.

Samples	Concentration (μg/mL)	% NO inhibition	% cell viability
KFM02	1.60	35.35 ± 14.86	113.21 ± 16.26
	12.50	46.55 ± 14.71	96.99 ± 6.16
	50.00	55.82 ± 12.00	94.95 ± 2.86
	100.00	54.83 ± 8.18	99.88 ± 3.57
SPK04	1.60	42.23 ± 16.07	112.79 ± 15.01
	12.50	44.87 ± 15.74	101.72 ± 10.90
	50.00	50.40 ± 10.48	97.65 ± 9.97
	100.00	59.65 ± 4.05	97.75 ± 10.96
KFM05	1.60	37.16 ± 18.86	104.95 ± 12.93
	12.50	54.65 ± 9.83	100.39 ± 5.87
	50.00	59.67 ± 3.50	99.41 ± 0.73
	100.00	63.43 ± 6.08	95.34 ± 4.14
Quercetin	1.60	64.17 ± 7.01	97.53 ± 5.03
	12.50	90.57 ± 3.94	83.52 ± 3.87
	50.00	91.05 ± 5.99	61.31 ± 2.19
	100.00	94.37 ± 3.31	57.05 ± 7.66
Doxorubicin	2.00		89.17 ± 5.65
	4.00		60.22 ± 5.19
	10.00		15.55 ± 6.72
	20.00		4.23 ± 4.06

Values are expressed as mean ± SEM.